• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

    9/29/25 9:30:00 AM ET
    $HOLX
    Medical Electronics
    Health Care
    Get the next $HOLX alert in real time by email

    HAUPPAUGE, N.Y., Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States. As Hologic transitions away from commercial activities related to the Fluoroscan Insight product line, Minicarm.com will continue to offer sales support for the remaining inventory, ensuring continuity and specialized service for U.S. customers.

    Minicarm.com Logo

    With this acquisition, Minicarm.com is uniquely positioned to offer U.S. customers who are seeking to purchase Hologic's market-leading Fluoroscan Insight FD system access to a select inventory, ensuring streamlined access, dedicated customer support, and comprehensive service.

    The Fluoroscan Insight FD is a compact, versatile imaging system designed to deliver high-quality, real-time fluoroscopic imaging for orthopedic and extremity procedures. Renowned for its exceptional image clarity, user-friendly design, and versatility, the Insight FD system enables physicians to make accurate clinical decisions while enhancing workflow efficiency.

    "We are thrilled to work closely with Hologic to make sure their Fluoroscan Insight FD systems are available to US customers at this pivotal time," said Joshua Bacon, VP, Minicarm.com. "This collaboration allows us to bring one of the most trusted and advanced Mini C-Arm systems to orthopedic practices, hospitals, and surgical centers nationwide."

    As part of the distribution agreement, Minicarm.com will:

    • Provide direct sales, marketing, and customer support across the U.S.

       
    • Offer comprehensive training and education for physicians and staff.

    Customers looking to upgrade their Hologic Fluoroscan Insight 2 or older Hologic Fluoroscan Insight FD Mini C-Arm systems, or those seeking more details about the new Hologic Fluoroscan Insight FD Mini C-Arm, can reach out to Minicarm.com. Call us at (800) 643-2998, email [email protected], or visit www.minicarm.com for more information.

    About Minicarm.com

    Minicarm.com is a leading distributor and service provider of advanced Mini C-Arm imaging solutions, founded by Christopher Bacon, the technical founder of Orthoscan. With deep product expertise, a strong commitment to customer service, and nationwide support, Minicarm.com is dedicated to expanding access to high-quality imaging technology for healthcare providers worldwide.

    About Hologic

    Hologic, Inc. (NASDAQ: HOLX) is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. Its products include industry-leading imaging, diagnostic, and surgical solutions.

    Media Contact: 

    Joshua Bacon 

    Minicarm.com

    Phone: (800) 643-2998 

    Email: [email protected]

    Website: www.minicarm.com

    Hologic Fluoroscan InSight FD Mini C-Arm

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/minicarmcom-named-exclusive-us-distributor-of-hologics-fluoroscan-insight-fd-mini-c-arm-302567568.html

    SOURCE Minicarm.com

    Get the next $HOLX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HOLX

    DatePrice TargetRatingAnalyst
    8/18/2025$80.00Hold → Buy
    Argus
    8/6/2025$87.00Sector Perform → Outperform
    RBC Capital Mkts
    7/9/2025$80.00Neutral → Buy
    Citigroup
    5/27/2025Hold
    Needham
    3/3/2025Buy → Hold
    Argus
    2/6/2025$80.00 → $75.00Outperform → Market Perform
    Leerink Partners
    2/3/2025Buy → Hold
    Needham
    12/13/2024Peer Perform
    Wolfe Research
    More analyst ratings

    $HOLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Volition Signs Co-Marketing and Services Agreement with Hologic

    HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ("Hologic") for the co-marketing of Volition's Nu.Q® Discover service. The Nu.Q® Discover service provides drug developers and scientists with a range of state-of-the-art assays for rapid epigenetic profiling in disease model development, preclinical testing, and clinical studies from discovery to being market ready. Under the agreement, Hologic (NASDAQ: HOLX) will co-market Nu.Q® Discover services of Volition with Hologic Customers for an initial one-year term. If successful, the aim is for

    9/29/25 9:30:00 AM ET
    $HOLX
    $VNRX
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

    HAUPPAUGE, N.Y., Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insight™ FD Mini C-Arm for resale in the United States. As Hologic transitions away from commercial activities related to the Fluoroscan Insight product line, Minicarm.com will continue to offer sales support for the remaining inventory, ensuring continuity and specialized service for U.S. customers. With this acquisition, Minicarm.com is uniquely positioned

    9/29/25 9:30:00 AM ET
    $HOLX
    Medical Electronics
    Health Care

    New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

    Research suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening Data from two groundbreaking studies evaluating the performance of Hologic's (NASDAQ: HOLX) artificial intelligence (AI)-powered mammography technology will be presented today at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting in Aberdeen, Scotland. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926785023/en/New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI "These results underscore AI's ability to make breast cancer screening more accura

    9/26/25 8:00:00 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 29, 2024 - FDA Roundup: October 29, 2024

    For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

    10/29/24 3:30:19 PM ET
    $HOLX
    Medical Electronics
    Health Care

    February 2, 2024 - FDA Roundup: February 2, 2024

    For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

    2/2/24 3:58:21 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    SEC Filings

    View All

    SEC Form 144 filed by Hologic Inc.

    144 - HOLOGIC INC (0000859737) (Subject)

    9/22/25 4:25:42 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic Inc. filed SEC Form 8-K: Leadership Update

    8-K - HOLOGIC INC (0000859737) (Filer)

    9/19/25 4:05:37 PM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form 10-Q filed by Hologic Inc.

    10-Q - HOLOGIC INC (0000859737) (Filer)

    7/31/25 7:39:05 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hologic upgraded by Argus with a new price target

    Argus upgraded Hologic from Hold to Buy and set a new price target of $80.00

    8/18/25 9:05:38 AM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Hologic from Sector Perform to Outperform and set a new price target of $87.00

    8/6/25 7:54:35 AM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic upgraded by Citigroup with a new price target

    Citigroup upgraded Hologic from Neutral to Buy and set a new price target of $80.00

    7/9/25 8:14:56 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    5/9/25 4:39:33 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, President and CEO Macmillan Stephen P sold $9,266,118 worth of shares (138,358 units at $66.97) and exercised 138,358 shares at a strike of $39.96 (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    9/23/25 4:10:08 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Div. President, GYN Surgical Schnittker Brandon covered exercise/tax liability with 69 shares, decreasing direct ownership by 1% to 6,094 units (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    6/3/25 4:19:30 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    5/9/25 4:39:33 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Financials

    Live finance-specific insights

    View All

    Hologic Announces Financial Results for Third Quarter of Fiscal 2025

    – Revenue of $1,023.8 Million Exceeds Guidance – – Company Reports GAAP Diluted EPS of $0.86; Non-GAAP Diluted EPS of $1.08 Exceeds Guidance – – In Fourth Quarter, Company Remains on Track for Solid Revenue Growth and Faster Non-GAAP EPS Growth – Hologic, Inc. (NASDAQ:HOLX) announced today the Company's financial results for the fiscal third quarter ended June 28, 2025. "We are pleased to have delivered revenue and non-GAAP earnings growth in the third quarter that exceeded our guidance ranges," said Stephen P. MacMillan, the Company's Chairman, President and Chief Executive Officer. "And we made great progress toward returning to better top- and bottom-line growth in the fourth qua

    7/30/25 4:01:00 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

    Hologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (866) 400-0049 (in the United States and Canada) or +1 (313) 209-4906 (for international callers) and referencing access code 5212316. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. Hologic will provide a live and webcast replay of the call on the Company's website at investors.holog

    7/2/25 4:05:00 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic Announces Financial Results for Second Quarter of Fiscal 2025

    – Revenue of $1,005.3 Million Slightly Exceeds Guidance – – Company Reports GAAP Diluted EPS of ($0.08); Non-GAAP Diluted EPS of $1.03 at High End of Guidance – – Company Maintains Annual Revenue Guidance, Lowers Guidance for GAAP and Non-GAAP EPS – Hologic, Inc. (NASDAQ:HOLX) announced today the Company's financial results for the fiscal second quarter ended March 29, 2025. "We delivered on our financial commitments in the second quarter," said Stephen P. MacMillan, the Company's Chairman, President and Chief Executive Officer. "Both revenue and non-GAAP EPS finished at the high ends of our guidance ranges, driven by our diagnostics and skeletal businesses, strong profitability, share

    5/1/25 4:01:00 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hologic Inc.

    SC 13G/A - HOLOGIC INC (0000859737) (Subject)

    11/14/24 1:28:29 PM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by Hologic Inc.

    SC 13G - HOLOGIC INC (0000859737) (Subject)

    2/14/24 10:04:34 AM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by Hologic Inc. (Amendment)

    SC 13G/A - HOLOGIC INC (0000859737) (Subject)

    2/9/23 11:22:19 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $HOLX
    Leadership Updates

    Live Leadership Updates

    View All

    Biote Announces CEO Retirement and Succession Plan

    Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of Directors Health Care Veteran Bret Christensen to Succeed Terry Weber as CEO and Director biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Terry Weber is retiring as Chief Executive Officer and stepping down from the Company's Board of Directors, effective as of February 1, 2025. She will be transitioning to Strategic Advisor to the Company's Board of Directors. Concurrently, Mr. Bret Christensen has been named Chief Executi

    1/30/25 4:10:00 PM ET
    $BTMD
    $HOLX
    $MYGN
    Medicinal Chemicals and Botanical Products
    Health Care
    Medical Electronics
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    CellMax Life Announces Expansion of Company Board With Leading Industry Experts

    Renowned industry experts join to aid in preparation around premarket approval for FirstSight SUNNYVALE, Calif., April 6, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced the appointment of Stanley N. Lapidus (Stan) as an advisory board member and Ronnie (Ron) Andrews as an independent board member. The announcement comes only one month after CellMax Life expanded its GI advisory board with luminaries in the GI arena. "Both Stan and Ron are pioneers in the diagnostics industry, with unique perspectives and proven track records of success," said Atul Sharan, CEO of CellMax Life. Stan is one of t

    4/6/23 9:00:00 AM ET
    $EXAS
    $HOLX
    Medical Specialities
    Health Care
    Medical Electronics

    IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

    MARLTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the election of five new members to its Board of Directors at the most recent meeting of its shareholders.  "We are extremely pleased to have Jim Tobin, Joe Capper, Glenn Muir, John Bakewell, and Dan Scavila all joining our board of directors," said Prof. Shlomo Ben-Haim, Chairman of the Board and Founder of Impulse Dynamics.  "This is an illustrious group to be adding to the board, and I am extremely pleased to be welcoming and working with all of them as we rapidly advance our goals for the company, for CCM therapy, and mo

    11/11/21 7:26:31 PM ET
    $BEAT
    $GMED
    $GTHX
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Electronics